Literature DB >> 12093053

Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.

J E Otterstad1, M G St John Sutton, G S Froeland, I Holme, T Skjaerpe, C Hall.   

Abstract

AIMS: The purpose of this prospective, observational study was to evaluate the relationship of left ventricular volumes, systolic function and plasma N-terminal proatrial natriuretic peptide (Nt-proANP) to cardiac morbidity and mortality in post-myocardial infarction patients with left ventricular ejection fraction > or =40%. METHODS AND
RESULTS: Two-dimensional echocardiographic recordings and Nt-proANP measurements were obtained in 834 patients who survived acute myocardial infarction. Patients were examined at 2-7 days and 3 months after the index infarction and followed up for 24 months. All measurements of left ventricular volumes, ejection fraction and Nt-proANP were performed in core laboratories. During follow-up 102 patients sustained one or more incidents of the combined primary end-point: cardiac death (n=11), recurrent infarction (n=55) or heart failure requiring hospitalization or treatment with an ACE inhibitor and a diuretic (n=52). Using Cox proportional hazards model, baseline Nt-proANP predicted these events (chi-square 25.3, P<0.0001), while baseline echo volumes and ejection fraction did not. During the subsequent 3-24 month period, 51 patients suffered a primary end-point: cardiac death (n=9), recurrent infarction (n=29), heart failure (n=21). An increase in left ventricular end-systolic volume was the strongest predictor for adverse events (chi-square 19.1, P<0.0001), especially for heart failure. Individual changes in Nt-proANP did not predict cardiac events, whereas both echocardiographic variables and Nt-proANP measured at 3 months had a prognostic impact on subsequent cardiac events (3-24 months).
CONCLUSIONS: In post-myocardial infarction patients with preserved left ventricular function (left ventricular ejection fraction > or =40%) baseline Nt-proANP, but not echocardiographic left ventricular volumes predicted adverse cardiac events. Early changes in left ventricular volumes and ejection fraction from baseline to 3 months had a further prognostic impact on subsequent events (3-24 months). Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093053     DOI: 10.1053/euhj.2001.2969

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  Measuring left ventricular volume and ejection fraction with the biplane Simpson's method.

Authors:  J E Otterstad
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

Review 2.  Screening for ventricular remodeling.

Authors:  Douglas S Lee; Thomas J Wang; Ramachandran S Vasan
Journal:  Curr Heart Fail Rep       Date:  2006-04

3.  Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.

Authors:  Johanna A Miettinen; Kari Ylitalo; Pirjo Hedberg; Kari Kervinen; Matti Niemelä; Marjaana Säily; Pirjo Koistinen; Eeva-Riitta Savolainen; Heikki Ukkonen; Mikko Pietilä; K E Juhani Airaksinen; Juhani Knuuti; Olli Vuolteenaho; Timo H Mäkikallio; Heikki V Huikuri
Journal:  Clin Res Cardiol       Date:  2010-10-17       Impact factor: 5.460

Review 4.  Prognostic value of combining echocardiography and natriuretic peptide levels in patients with heart failure.

Authors:  Wei-Hsian Yin; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Curr Heart Fail Rep       Date:  2012-06

5.  Measurements of left ventricular volumes and ejection fraction with three-dimensional echocardiography: feasibility and agreement compared to two-dimensional echocardiography.

Authors:  Vidar Ruddox; Thor Edvardsen; Morten Bækkevar; Jan Erik Otterstad
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-28       Impact factor: 2.357

6.  Plasma ProBNP Is Not a Specific Marker for Transient Myocardial Ischemia.

Authors:  Khawar Maqsood; Muhammad T Shakoor; James R Cook; Gregory R Giugliano; Amir Lotfi
Journal:  J Clin Med Res       Date:  2015-05-08

7.  Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.

Authors:  Christophe Bauters; Emilie Dubois; Sina Porouchani; Eric Saloux; Marie Fertin; Pascal de Groote; Nicolas Lamblin; Florence Pinet
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

8.  Atrial Natriuretic Peptides, Right Atrial Infarction and Prognosis of Patients with Myocardial Infarction-A Single-Center Study.

Authors:  Michal Kacprzak; Magdalena Brzeczek; Marzenna Zielinska
Journal:  Biomolecules       Date:  2021-12-04

9.  Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction.

Authors:  Jan Erik Otterstad; Ingvild Billehaug Norum; Vidar Ruddox; An Chau Maria Le; Bjørn Bendz; John Munkhaugen; Ole Klungsøyr; Thor Edvardsen
Journal:  Int J Cardiovasc Imaging       Date:  2021-07-29       Impact factor: 2.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.